Avation’s Jeff Chatfield on strategic bond issuance and fleet growth outlook (LON:AVAP) 20 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Meren Energy $100M Dividends and Debt Slashed as Nigerian and Namibian Oil Assets Power Ahead (Video)
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Firering Strategic Minerals Secures Settlement Funds to Boost Limeco Option – Shard Capital 17 November 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
Avation’s Jeff Chatfield on strategic bond issuance and fleet growth outlook (LON:AVAP) 20 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Meren Energy $100M Dividends and Debt Slashed as Nigerian and Namibian Oil Assets Power Ahead (Video)
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Firering Strategic Minerals Secures Settlement Funds to Boost Limeco Option – Shard Capital 17 November 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
PureTech Health plc (PRTC) Stock Analysis: Unveiling a Potential 182% Upside for Patient Investors 12 September 2025
MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a Biotech Gem with 279.80% Potential Upside 12 September 2025
Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Investors Eye 157% Potential Upside with Biotech Innovator 12 September 2025
Emergent BioSolutions Inc. (EBS) Stock Analysis: A Closer Look at a Potential 64% Upside 12 September 2025
KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: 113.82% Potential Upside Sparks Investor Interest 12 September 2025
Castle Biosciences (CSTL) Stock Analysis: A 56.59% Potential Upside in the Healthcare Diagnostics Sector 12 September 2025
Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech Gem with a 230% Upside Potential 12 September 2025
Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with a Focus on Innovation 12 September 2025
Bioventus Inc. (BVS) Stock Analysis: Unveiling a Potential 75% Upside in the Medical Devices Sector 12 September 2025
Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Navigating a 60.78% Potential Upside Amid Transformative Immunology Advances 12 September 2025
Arvinas, Inc. (ARVN) Stock Analysis: Exploring a 136% Upside Potential with Innovative PROTAC Technology 12 September 2025
Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector 12 September 2025
Tourmaline Bio, Inc. (TRML) Stock Analysis: Navigating a High RSI Amidst Biotech Innovations 12 September 2025
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Eyeing a Massive 342% Upside with Strong Analyst Support 12 September 2025
Bicycle Therapeutics plc (BCYC) Stock Analysis: Uncovering a Potential 240% Upside in the Biotechnology Sector 12 September 2025
Standard BioTools Inc. (LAB) Stock Analysis: Navigating a 33% Potential Upside in the Volatile Medical Devices Sector 12 September 2025
Owens & Minor, Inc. (OMI) Stock Analysis: Navigating a Challenging Market with 11.82% Upside Potential 12 September 2025
NB Private Equity Partners: Buybacks, Exits and a Quiet Rebound Investors Are Missing (Video) 24 November 2025
Verge Technologies: Why SentientDB Is Mission-Critical in a Multi-Cloud World (Video) 24 November 2025
Cavendish Plc Market Resilience, Deep Value, and a 7.5% Yield That’s Hard to Ignore (Video) 24 November 2025
Meren Energy $100M Dividends and Debt Slashed as Nigerian and Namibian Oil Assets Power Ahead (Video) 19 November 2025
Avation’s Jeff Chatfield on strategic bond issuance and fleet growth outlook (LON:AVAP) 20 November 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Firering Strategic Minerals Secures Settlement Funds to Boost Limeco Option – Shard Capital 17 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
